Maintaining mitochondrial membrane impermeability: An opportunity for new therapy in glaucoma?

被引:47
作者
Tatton, WG
Chalmers-Redman, RME
Sud, A
Podos, SM
Mittag, TW
机构
[1] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Dept Ophthalmol, New York, NY 10029 USA
[3] Univ London, Sch Pharm, London WC1N 1AX, England
关键词
apoptosis; glaucoma; mitochondrial membrane permeability; retinal ganglion cell loss;
D O I
10.1016/S0039-6257(01)00207-7
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Apoptosis may contribute to retinal ganglion cell loss in glaucoma and glaucoma models. Recent research has suggested that mitochondrially dependent apoptosis signaling may contribute to apoptosis in a rat model of glaucoma involving chronic increases in intraocular pressure. In some for-ms of apoptosis, mitochondrially dependent signaling involves increases in mitochondrial membrane permeability and the mitochondrial release of factors that signal for cell degradation. Opening of a multi-protein, mitochondrial megapore is one factor Brat contributes to the increased permeability and some anti-apoptotic proteins, particularly BCL-5 and BCL-X-L, bind at the megapore and facilitate megapore closure and reduce increases in mitochondria membrane permeability. Phosphorylated protein kinase B (Akt) serves as an integrator for cellular survival signals and facilitates the megapore actions of BCL-2 and BCL-X-L, which could protect retinal ganglion cells against insults chat induce apoptosis. Several anti-apoptotic agents are being evaluated for use in glaucoma, including brimonidine and propargylamines, which oppose mitochondrially dependent apoptosis through pathway involving phosphorylated Akt. (C) 2001 by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:S277 / S283
页数:7
相关论文
共 85 条
[71]   Apoptosis in neurodegenerative diseases: the role of mitochondria [J].
Tatton, WG ;
Olanow, CW .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1999, 1410 (02) :195-213
[72]  
Tenneti L, 1998, J NEUROCHEM, V71, P946
[73]   An experimental basis for implicating excitotoxicity in glaucomatous optic neuropathy [J].
Vorwerk, CK ;
Gorla, MSR ;
Dreyer, EB .
SURVEY OF OPHTHALMOLOGY, 1999, 43 :S142-S150
[74]  
Wadia JS, 1998, J NEUROSCI, V18, P932
[75]  
Wahlin KJ, 2000, INVEST OPHTH VIS SCI, V41, P927
[76]   BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) PREVENTS LESION-INDUCED AXONAL DIEBACK IN YOUNG-RAT OPTIC-NERVE [J].
WEIBEL, D ;
KREUTZBERG, GW ;
SCHWAB, ME .
BRAIN RESEARCH, 1995, 679 (02) :249-254
[77]  
Wilson BE, 1996, MOL CELL BIOL, V16, P5546
[78]   l-deprenyl, blocking apoptosis and regulating gene expression in cultured retinal neurons [J].
Xu, L ;
Ma, JF ;
Seigel, GM ;
Ma, JX .
BIOCHEMICAL PHARMACOLOGY, 1999, 58 (07) :1183-1190
[79]   The Ras/phosphatidylinositol 3-kinase and Ras/ERK pathways function as independent survival modules each of which inhibits a distinct apoptotic signaling pathway in sympathetic neurons [J].
Xue, LZ ;
Murray, JH ;
Tolkovsky, AM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) :8817-8824
[80]   BAD, A HETERODIMERIC PARTNER FOR BCL-X(L) AND BCL-2, DISPLACES BAX AND PROMOTES CELL-DEATH [J].
YANG, E ;
ZHA, JP ;
JOCKEL, J ;
BOISE, LH ;
THOMPSON, CB ;
KORSMEYER, SJ .
CELL, 1995, 80 (02) :285-291